KEISHLA CARDE GONZALEZ: Open Payments
NPI 1588350581 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,275 in 104 payments from 16 companies in 2025. Trend: 2023 $1,435 · 2024 $2,607 · 2025 $2,275
Food & beverage: $2,275
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $375 |
| PFIZER INC. | 12 | $325 |
| GlaxoSmithKline, LLC. | 11 | $281 |
| ABBVIE INC. | 13 | $234 |
| Amgen Inc. | 12 | $209 |
| Lilly USA, LLC | 15 | $200 |
| Novo Nordisk Inc | 11 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $116 |
| Exact Sciences Corporation | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, MOUNJARO, FARXIGA, AIRSUPRA, OTEZLA, UBRELVY, QULIPTA.
Industry payments across FL — which companies pay providers there.
